Maria C. Rodriguez-Oroz

Best Publications

• Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

  Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand

  2901
  Citations

• Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up

  M C Rodriguez-Oroz;J A Obeso;A E Lang;J L Houeto

  1306
  Citations

• Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease

  Peter Redgrave;Manuel Rodriguez;Manuel Rodriguez;Yoland Smith;Yoland Smith;Maria C. Rodriguez-Oroz;Maria C. Rodriguez-Oroz

  1259
  Citations

• Pathophysiology of the basal ganglia in Parkinson's disease.

  José A. Obeso;Maria C. Rodriguez-Oroz;Manuel Rodriguez;José L. Lanciego

  1068
  Citations

• Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

  Maria C Rodriguez-Oroz;Maria C Rodriguez-Oroz;Marjan Jahanshahi;Paul Krack;Paul Krack;Irene Litvan

  1068
  Citations

• Missing pieces in the Parkinson's disease puzzle.

  Jose A Obeso;Maria C Rodriguez-Oroz;Christopher G Goetz;Concepcion Marin;Concepcion Marin

  1002
  Citations

• MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

  Irene Litvan;Dag Aarsland;Charles H. Adler;Jennifer G. Goldman

  957
  Citations

• Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease

  Jose A. Obeso;Maria Cruz Rodríguez-Oroz;Beatriz Benitez-Temino;Franscisco J. Blesa

  861
  Citations

• Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains

  Lydia Alvarez-Erviti;Maria C. Rodriguez-Oroz;J. Mark Cooper;Cristina Caballero

  632
  Citations

• The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics

  Maria C. Rodriguez-Oroz;Manuel Rodriguez;Jorge Guridi;Klaus Mewes

  574
  Citations

• Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.

  Elena Moro;Andres M. Lozano;Pierre Pollak;Yves Agid

  547
  Citations

• The impact of deep brain stimulation on executive function in Parkinson's disease.

  M. Jahanshahi;C. M. A. Ardouin;R. G. Brown;J. C. Rothwell

  538
  Citations

• Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.

  M C Rodriguez;J A Obeso;C W Olanow

  520
  Citations

• Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

  Matthieu F. Bastide;Wassilios G. Meissner;Barbara Picconi;Stefania Fasano

  511
  Citations

• The basal ganglia in Parkinson's disease: Current concepts and unexplained observations

  Jose A. Obeso;Concepcio Marin;C. Rodriguez-Oroz;Javier Blesa

  451
  Citations

• Coupling between Beta and High-Frequency Activity in the Human Subthalamic Nucleus May Be a Pathophysiological Mechanism in Parkinson's Disease

  Jon López-Azcárate;Mikel Tainta;María C. Rodríguez-Oroz;Miguel Valencia

  434
  Citations

• Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders

  Valerie Voon;Pierre-Olivier Fernagut;Jeff Wickens;Christelle Baunez

  429
  Citations

• Deep brain stimulation: postoperative issues.

  Günther Deuschl;Jan Herzog;Galit Kleiner-Fisman;Cynthia Kubu

  393
  Citations

• Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor

  Robert E. Gross;Paul Krack;Maria C. Rodriguez-Oroz;Ali R. Rezai

  367
  Citations

• Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.

  Valerie Voon;Valerie Voon;T Celeste Napier;Michael J Frank;Veronique Sgambato-Faure;Veronique Sgambato-Faure

  337
  Citations